Bøger af Manel Jellouli

La crescita è un obiettivo centrale nella gestione dei bambini con malattia renale cronica (CKD). Questo libro passa in rassegna i modelli di crescita osservati nei bambini con CKD, nonché le cause dei disturbi della crescita e i segni e le cause della perdita di energia proteica nella CKD pediatrica.Vengono inoltre esaminati i metodi di valutazione della crescita e dello stato nutrizionale e i limiti di queste misure nella CKD.Saranno discusse le strategie di gestione per ottimizzare la crescita e la nutrizione nei bambini con CKD, compreso l'uso dell'ormone della crescita ricombinante. Infine, il capitolo si conclude con informazioni sullo sviluppo neurologico del bambino con CKD.

Das Wachstum ist ein zentrales Ziel bei der Behandlung von Kindern mit chronischer Nierenerkrankung (CKD). Dieses Buch gibt einen Überblick über die bei Kindern mit KRK beobachteten Wachstumsmuster sowie über die Ursachen von Wachstumsstörungen und die Anzeichen und Ursachen des Verlusts an Proteinenergie bei der pädiatrischen KRK.Die Methoden zur Beurteilung des Wachstums und des Ernährungszustands sowie die Grenzen dieser Messungen bei KHK werden ebenfalls besprochen.Managementstrategien zur Optimierung von Wachstum und Ernährungszustand bei Kindern mit KHK, einschließlich der Verwendung von rekombinantem Wachstumshormon. Schließlich schließt das Kapitel mit Informationen über die neurologische Entwicklung von Kindern mit KHK.

Growth is a central objective in the management of children with chronic kidney disease (CKD). This book reviews the growth patterns observed in children with CKD, as well as the causes of growth disorders and the signs and causes of protein energy loss in pediatric CKD.Methods of assessing growth and nutritional status, and the limitations of these measures in CKD, will also be reviewed.Management strategies to optimize growth and nutrition in children with CKD, including the use of recombinant growth hormone. Finally, the chapter concludes with information on the neurological development of the child with CKD.

O crescimento é um objetivo central no tratamento de crianças com doença renal crónica (DRC). Este livro analisa os padrões de crescimento observados em crianças com DRC, bem como as causas das perturbações do crescimento e os sinais e causas da perda de energia proteica na DRC pediátrica.São também revistos os métodos de avaliação do crescimento e do estado nutricional e as limitações destas medidas na DRC.Serão discutidas estratégias de gestão para otimizar o crescimento e a nutrição em crianças com DRC, incluindo a utilização da hormona de crescimento recombinante. Por fim, o capítulo conclui com informações sobre o desenvolvimento neurológico da criança com DRC.

Primary hyperoxaluria is a group of inherited diseases with autosomal recessive inheritance (ARD), resulting from an inborn disorder of hepatic glyoxylate metabolism responsible for excessive oxalate production and increased urinary oxalate excretion.This disorder leads to precipitation of highly insoluble oxalate in the form of calcium oxalate crystals in the kidneys, resulting in nephrocalcinosis, recurrent urinary lithiasis (LU) and frequent progression to chronic renal failure (CKD). When renal function is impaired, elevated oxalemia leads to systemic oxalosis, corresponding to calcium oxalate deposition in various tissues, mainly bone, but also the cardiovascular system, skin, retina, etc.

Lupus nephropathy (LN) affects 50-75% of children with systemic lupus erythematosus (SLE). Lupus nephritis is more common and severe in children and has been associated with high morbidity and mortality. This review aimed to describe the general aspects of LN and its peculiarities when affecting children and adolescents, while focusing on the etiopathogenesis of the disease, clinical manifestations, renal tissue alterations, as well as therapeutic management.